Atomy India, a subsidiary of South Korean direct selling firm Atomy, is planning to make an investment of around Rs 250 crore for setting up manufacturing units in the country by 2025 to cater to the domestic market and exports.
The company plans to manufacture its range of food and supplements and is scouting for land in NCR for setting up the units.
Moreover, Atomy has unveiled its comprehensive plans for the Indian market. It would launch its Global Sourcing Global Sales (GSGS) plan by 2022, under which it will export Ayurvedic Indian products to different parts of the world.
Atomy India is having collaborations with 10 Korean manufacturers and has shown interest in their growth in India.
Atomy has its global distribution network in almost 50 plus countries. Currently, Atomy India meets the requirements of the Indian market through import from the parent company Atomy.
It is targetting a revenue of approximately Rs 80 crore for FY22. It has plans to add more products in the health supplements and food categories.
In one year it has launched Korean products in India including skincare, The Fame and plans to launch more products in Health Supplements and Food categories.